Pulmotect Provides Results from Two Phase-2 Trials of PUL-042 Against COVID-19
01 Dec 2021 //
BUSINESSWIRE
Pulmotect Gives +ve Topline Results Phase-2 Trial of PUL-042 against COVID-19
24 Sep 2021 //
BUSINESSWIRE
01 Dec 2021 //
BUSINESSWIRE
24 Sep 2021 //
BUSINESSWIRE